Medications

US company withdraws ALS drug after it fails in trial

Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after clinical data found no evidence the drug worked.

Neuroscience

What is frontotemporal dementia?

Frontotemporal dementia (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement. Some FTD forms are inherited, and some are not. Typically, people develop FTD symptoms ...

Diseases, Conditions, Syndromes

EU watchdog gives new ALS treatment thumbs up

Europe's medicines watchdog gave the green light Friday to a new treatment for a rare form of the neurodegenerative disease ALS, saying it should reduce the symptoms of the deadly illness.

page 3 from 40